article thumbnail

Star-studded digital avatar startup Genies launches NFT fashion marketplace

TechCrunch LA

” Genies last earned a $1 billion valuation from heavy-hitting tech investors including Silver Lake and Mary Meeker’s Bond Capital during its most recent raise, a $150 million Series C round announced in April.

Geni 219
article thumbnail

Final Draft Acquired By Cast & Crew Entertainment

socalTECH

Cast & Crew said the buy will help expand its suite of technology solutions. The acquisition was supported by private equity investor Silver Lake Partners, which is the majority owner of Cast & Crew. Financial terms of the acquisition were not announced. READ MORE>>.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Renovate America Raises $90M For Energy Saving Financing

socalTECH

San Diego-based Renovate America has raised $90M in an equity financing round, from Silver Lake Kraftwerk, DFJ Growth, and others, the company disclosed Thursday. Renovate America has previously received funding from Valor Equity Partners.

article thumbnail

Zuma Ventures: Creating A New Technology Startup Model

socalTECH

David Carter and Allen Hurff are two startup veterans, who believe they have a new formula to help create early stage, technology companies, through their new "startup studio", Zuma Ventures (www.zumavc.com). When that happened, I came out to LA and helped to co-found Amplify.

Startup 231
article thumbnail

A Chat With Jamie Montgomery On How LA's Tech Ecosystem Has Grown

socalTECH

The conference is run by Jamie Montgomery , one of the local industry's pioneers in venture capital and investment. Jamie is currently also co-founder of March Capital Partners, in addition to running the summit. In terms of that, they are people like Vista Equity, particularly, but also Summit, TPG, KKR, and Silver Lake.

article thumbnail

Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More

Xconomy

You can help with that by sending us frequent feedback via email (first initial-last name-at-xconomy.com) and Twitter. Topics ranged from the worries over CRISPR genome editing and Wild West biohacking, to Nobel Prize-fueled drug approvals and the headaches around drug prices (even for drugs meant to cure headaches).

Pricing 69